Health
New clues why gold standard treatment for bipolar disorder doesn’t work for majority of patients – Hindustan Times
Lithium is considered the gold standard for treating bipolar disorder (BD), but nearly 70 per cent of people with BD don’t respond to it. This leaves them at risk…
Lithium is considered the gold standard for treating bipolar disorder (BD), but nearly 70 per cent of people with BD don’t respond to it. This leaves them at risk for debilitating, potentially life-threatening. Researchers at the Salk Institute have found that the culprit may lie in gene activity — or lack of it.
A new study led by Salk Professor and President Rusty Gage, which was published in the journal Molecular Psychiatry on January 4, 2021, shows that decreased activation of a gene called…
-
Business12 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News7 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
Business5 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
General12 hours agoDoctors in Gaza running out of vital medicines as Israeli aid blockade stretches into sixth week